Annual Debt To Equity
-2.85
-3.57-495.83%
December 31, 2023
Summary
- As of February 12, 2025, EIGR annual debt to equity ratio is -2.85, with the most recent change of -3.57 (-495.83%) on December 31, 2023.
- During the last 3 years, EIGR annual debt to equity has fallen by -3.19 (-938.24%).
- EIGR annual debt to equity is now -495.83% below its all-time high of 0.72, reached on December 31, 2022.
Performance
EIGR Debt To Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Debt To Equity
-2.85
+22.55+88.78%
December 31, 2023
Summary
- As of February 12, 2025, EIGR quarterly debt to equity ratio is -2.85, with the most recent change of +22.55 (+88.78%) on December 31, 2023.
- Over the past year, EIGR quarterly debt to equity has dropped by -3.57 (-495.83%).
- EIGR quarterly debt to equity is now -207.95% below its all-time high of 2.64, reached on June 30, 2023.
Performance
EIGR Quarterly Debt To Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Debt To Equity Formula
Debt To Equity = Total Debt
Shareholders Equity
Total Debt
Shareholders Equity
Shareholders Equity
EIGR Debt To Equity Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -495.8% | -495.8% |
| 3 y3 years | -938.2% | -938.2% |
| 5 y5 years | -850.0% | -850.0% |
EIGR Debt To Equity Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -495.8% | at low | -207.9% | +88.8% |
| 5 y | 5-year | -495.8% | at low | -207.9% | +88.8% |
| alltime | all time | -495.8% | at low | -207.9% | +88.8% |
Eiger BioPharmaceuticals Debt To Equity History
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2023 | -2.85(-495.8%) | -2.85(-88.8%) |
| Sep 2023 | - | -25.40(-1062.1%) |
| Jun 2023 | - | 2.64(+133.6%) |
| Mar 2023 | - | 1.13(+56.9%) |
| Dec 2022 | 0.72(+63.6%) | 0.72(+44.0%) |
| Sep 2022 | - | 0.50(+31.6%) |
| Jun 2022 | - | 0.38(+15.2%) |
| Mar 2022 | - | 0.33(-25.0%) |
| Dec 2021 | 0.44(+29.4%) | 0.44(+25.7%) |
| Sep 2021 | - | 0.35(+20.7%) |
| Jun 2021 | - | 0.29(+16.0%) |
| Mar 2021 | - | 0.25(-26.5%) |
| Dec 2020 | 0.34(-40.4%) | 0.34(-2.9%) |
| Sep 2020 | - | 0.35(-36.4%) |
| Jun 2020 | - | 0.55(-26.7%) |
| Mar 2020 | - | 0.75(+31.6%) |
| Dec 2019 | 0.57(+50.0%) | 0.57(+26.7%) |
| Sep 2019 | - | 0.45(+25.0%) |
| Jun 2019 | - | 0.36(-42.9%) |
| Mar 2019 | - | 0.63(+65.8%) |
| Dec 2018 | 0.38 | 0.38(-49.3%) |
| Sep 2018 | - | 0.75(+82.9%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2018 | - | 0.41(-60.2%) |
| Mar 2018 | - | 1.03(+53.7%) |
| Dec 2017 | 0.67(+86.1%) | 0.67(-43.7%) |
| Sep 2017 | - | 1.19(+65.3%) |
| Jun 2017 | - | 0.72(+50.0%) |
| Mar 2017 | - | 0.48(+33.3%) |
| Dec 2016 | 0.36(>+9900.0%) | 0.36(>+9900.0%) |
| Sep 2016 | - | 0.00(0.0%) |
| Jun 2016 | - | 0.00(0.0%) |
| Mar 2016 | - | 0.00(0.0%) |
| Dec 2015 | 0.00(-100.0%) | 0.00(0.0%) |
| Sep 2015 | - | 0.00(-100.0%) |
| Jun 2015 | - | 0.25(+38.9%) |
| Mar 2015 | - | 0.18(+28.6%) |
| Dec 2014 | 0.14(+27.3%) | 0.14(+16.7%) |
| Sep 2014 | - | 0.12(>+9900.0%) |
| Jun 2014 | - | 0.00(0.0%) |
| Mar 2014 | - | 0.00(-100.0%) |
| Dec 2013 | 0.11(>+9900.0%) | 0.11(>+9900.0%) |
| Sep 2013 | - | 0.00(0.0%) |
| Jun 2013 | - | 0.00 |
| Dec 2012 | 0.00(-100.0%) | - |
| Dec 2011 | -0.17 | - |
FAQ
- What is Eiger BioPharmaceuticals annual debt to equity ratio?
- What is the all time high annual debt to equity for Eiger BioPharmaceuticals?
- What is Eiger BioPharmaceuticals annual debt to equity year-on-year change?
- What is Eiger BioPharmaceuticals quarterly debt to equity ratio?
- What is the all time high quarterly debt to equity for Eiger BioPharmaceuticals?
- What is Eiger BioPharmaceuticals quarterly debt to equity year-on-year change?
What is Eiger BioPharmaceuticals annual debt to equity ratio?
The current annual debt to equity of EIGR is -2.85
What is the all time high annual debt to equity for Eiger BioPharmaceuticals?
Eiger BioPharmaceuticals all-time high annual debt to equity ratio is 0.72
What is Eiger BioPharmaceuticals annual debt to equity year-on-year change?
Over the past year, EIGR annual debt to equity ratio has changed by -3.57 (-495.83%)
What is Eiger BioPharmaceuticals quarterly debt to equity ratio?
The current quarterly debt to equity of EIGR is -2.85
What is the all time high quarterly debt to equity for Eiger BioPharmaceuticals?
Eiger BioPharmaceuticals all-time high quarterly debt to equity ratio is 2.64
What is Eiger BioPharmaceuticals quarterly debt to equity year-on-year change?
Over the past year, EIGR quarterly debt to equity ratio has changed by -3.57 (-495.83%)